The tumour glyco-code as a novel immune checkpoint for immunotherapy
The tumour glyco-code as a novel immune checkpoint for immunotherapy
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Could the specific glycosylation signatures associated with tumour cells be harnessed for immunotherapy purposes? In this Opinion, the authors propose that the tumour glyco-code may represent a novel immune checkpoint that could be targeted in the clinic.
Tumour growth is accompanied by tumour evasion of the immune system, a process that is faci...
Alternative Titles
Full title
The tumour glyco-code as a novel immune checkpoint for immunotherapy
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1994360653
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1994360653
Other Identifiers
ISSN
1474-1733
E-ISSN
1474-1741
DOI
10.1038/nri.2018.3
